GRAFTIDE M 500MG TABLET

Graftide M 500mg Tablet is an immune suppressant with an active ingredient named Mycophenolate mofetil. It is part of the inosine monophosphate dehydrogenase (IMPDH) inhibitor class. It is prescribed to avoid organ rejection in patients who have had the organs of a donor (such as heart, kidney or even liver transplantation). It is usually prescribed as part of a treatment combination which includes other immunosuppressive medications.
This medication is not recommended during pregnancy because of the risk of miscarriage and congenital disabilities. It should not be used for pregnant women unless there are no other alternatives and the possible advantages outweigh the risks. Women who are pregnant or nearing the age of birth are strongly advised to use the most effective contraception available when taking this tablet to avoid pregnancies. Live vaccines shouldn’t be administered when a person is taking Graftide M 500 mg Tablet due to the reduced effectiveness and the possibility of contracting. People taking this medication must not give blood during treatment and, at minimum, six weeks after having stopped treatment. This ensures the drug is entirely cleared out of the body before blood donation.
It is usually advised not to use this medication when allergic to the drug or other ingredients. Inform your physician about heart or liver disease before starting the treatment. Because this medication reduces the body’s immune system, it may increase skin cancer risk. People should reduce their exposure to sun or UV (UV) radiation. Contact your physician immediately when you experience any bleeding on the skin, fever or any other unidentified dizziness, fatigue, tiredness of the eyes or skin or eyes, vision impairment decreased urinary output, or seizures following this medication. Graftide M 500 mg Tablet is an immunosuppressive medication. It can affect the infant’s developing immune system and should not be used when breastfeeding. In certain instances, alternatives to drugs that have better safety profiles while breastfeeding might be thought of as.